Harvard Bioscience Revenue, Profits - HBIO Quarterly Income Statement

Add to My Stocks
$4.7 $0.15 (3.3%) HBIO stock closing price Feb 16, 2018 (Closing)

Financial analysis of Harvard Bioscience involves more than just checking the Harvard Bioscience stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the HBIO income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of -0.63% when compared to the same period in the past. Along with Harvard Bioscience assets and Harvard Bioscience free cash flow, Harvard Bioscience profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 Q3 is $-0.42M and the 2017 Q3 revenue is $25.05M.

View and download details of revenue and profits for Harvard Bioscience for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Harvard Bioscience Revenues or Net Sales
25.05M25.21M24.16M26.42M25.01M26.14M26.96M28.37M25.73M
Cost Of Goods Sold (COGS)13.41M13.92M12.65M14.32M13.31M14.46M14.01M15.46M14M
Harvard Bioscience Gross Profit
11.63M11.28M11.49M12.11M11.69M11.67M12.94M12.94M11.72M
Research & Development Expense1.53M1.29M1.28M1.17M1.3M1.5M1.42M1.55M1.42M
Selling General & Admin Expense9.61M9.38M10.25M11.45M10.46M10.32M11.06M10.61M10.4M
Income Before Depreciation Depletion Amortization---0.03M-0.49M-0.08M-0.15M---0.1M
Depreciation Depletion Amortization---------
Non Operating Income-0.08M-0.28M-0.24M----0.05M-0.23M-0.11M
Interest Expense---------
Harvard Bioscience Pretax Income
-0.41M-0.46M-1.04M-0.99M-0.88M-0.76M-0.44M-0.33M-1.09M
Provision for Income Taxes--0.08M----0.05M-16.8M-0.24M
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-0.42M-0.38M-1.07M-1.32M-1.64M-0.71M-0.64M-17.14M-0.85M
Extraordinary Items & Discontinued Operations---------
Harvard Bioscience Profit/ Loss (Net Income)
-0.42M-0.38M-1.07M-1.32M-1.64M-0.71M-0.64M-17.14M-0.85M
Average Shares used to compute Diluted EPS34.84M34.7M34.58M34.38M34.33M34.13M34.01M33.95M33.93M
Average Shares used to compute Basic EPS34.84M34.7M34.58M34.38M34.33M34.13M34.01M33.95M33.93M
Income Before Nonrecurring Items---0.15M------
Income from Nonrecurring Items-0.66M-0.66M-0.92M-1.78M-2.13M-1.7M-1.57M-17.6M-1.24M
Harvard Bioscience Earnings Per Share Basic Net
-0.01-0.01-0.03-0.04-0.05-0.02-0.02-0.51-0.02
Harvard Bioscience Earnings Per Share Diluted Net
-0.01M-0.01M-0.03M-0.04M-0.05M-0.02M-0.02M-0.51M-0.02M
EPS Diluted Before Nonrecurring Items0.010.010.000.010.010.010.020.010.02
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Harvard Bioscience stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that HBIO stock has a topline or revenue of $25.05M for 2017 Q3 as per this Harvard Bioscience revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. HBIO stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the HBIO income statement, one can check the Harvard Bioscience historical stock prices to check how the price has moved with time.

Harvard Bioscience Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.62
Dividend Yield
0%